Companies › STIM

NEURONETICS INC (STIM)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001227636 · EDGAR filings · Updated 2026-07-23

NEURONETICS INC (STIM) has reported institutional ownership of 60.1%, with 99 institutional managers holding positions valued at $60.4M per the latest 13F reporting period. SEC filings include an active notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01), substantial-doubt (going concern) disclosure per the filings.

Filings this week (2)

• 2026-07-23 — Insider transaction reported (Form 4)
• 2026-07-23 — Initial insider ownership filed (Form 3)

Every filing links to the official SEC document. Real-time filing alerts for this company are available inside the app.

Latest updates

• 2026-07-20 — Current report (8-K) filed
• 2026-07-15 — Insider transaction reported (Form 4)
• 2026-07-13 — Initial insider ownership filed (Form 3)
• 2026-06-23 — Current report (8-K) filed

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, NEURONETICS INC has 99 institutional holders and institutional ownership of 60.1%.

Insider activity

Insiders reported 43 transactions (8 buys, 15 sells) across 13 reporting insiders, with a net reported value of −$10.5M.

Data flags from SEC filings

Related companies

ALDEYRA THERAPEUTICS INC (ALDX) · Pliant Therapeutics Inc (PLRX) · AVITA MEDICAL INC (RCEL) · ALPHA COGNITION INC (ACOG) · ALVOTECH (ALVO) · LAKELAND INDUSTRIES INC (LAKE)